Xencor, Inc. (XNCR)
12.38
-0.06
(-0.44%)
USD |
NASDAQ |
May 13, 16:00
12.38
0.00 (0.00%)
After-Hours: 20:00
Xencor Cash from Investing (Quarterly) : 26.68M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | -7.975M |
| Ultragenyx Pharmaceutical, Inc. | -49.00M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Amgen, Inc. | -716.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -67.63M |
| Cash from Financing (Quarterly) | 0.95M |
| Free Cash Flow | -188.84M |
| Free Cash Flow Per Share (Quarterly) | -0.9069 |
| Free Cash Flow to Equity (Quarterly) | -55.66M |
| Free Cash Flow to Firm (Quarterly) | -63.53M |
| Free Cash Flow Yield | -20.43% |